Metabolic‐associated fatty liver disease and hepatocellular carcinoma: a prospective study of characteristics and response to therapy

Background and Aim The rising incidence of hepatocellular carcinoma (HCC) in Australia is related to increasing rates of metabolic‐associated fatty liver disease (MAFLD). This study aimed to prospectively characterize the metabolic profile, lifestyle, biometric features, and response to treatment of...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of gastroenterology and hepatology Vol. 39; no. 6; pp. 1048 - 1056
Main Authors:	Batt, NM, Rodrigues, B, Bloom, S, Sawhney, R, George, ES, Hodge, A, Vootukuru, N, McCrae, C, Sood, Surbhi, Roberts, SK, Dev, A, Bell, S, Thompson, A, Ryan, MC, Kemp, W, Gow, PJ, Sood, Siddharth, Nicoll, AJ
Format:	Journal Article
Language:	English
Published:	Australia Wiley Subscription Services, Inc 01-06-2024
Subjects:	Aged Australia - epidemiology Carcinoma, Hepatocellular - epidemiology Carcinoma, Hepatocellular - etiology Carcinoma, Hepatocellular - therapy Cirrhosis Cohort Studies Dyslipidemia Fatty liver Fatty Liver - diagnosis Fatty Liver - epidemiology Fatty Liver - etiology Fatty Liver - therapy Female HCC Hepatocellular carcinoma Humans Life Style Lifestyle Liver cancer Liver diseases Liver Neoplasms - epidemiology Liver Neoplasms - etiology Liver Neoplasms - therapy MAFLD Male Metabolic syndrome Metabolic Syndrome - epidemiology Metabolism Middle Aged Non-alcoholic Fatty Liver Disease - epidemiology Non-alcoholic Fatty Liver Disease - therapy Prospective Studies Statins Treatment Outcome Australia Liver cancer MAFLD HCC Lifestyle Metabolic syndrome
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!